Meril Italy Srl v. Edwards Lifesciences Corporation

App_45041/2024

This UPC Court of Appeal decision addressed requests for the expedition of appeals concerning the validity of European patent EP 3 646 825, which relates to a prosthetic heart valve. The court ultimately rejected Meril's pleas for an expedited timeline. The ruling reinforces that procedural concerns regarding potential injunction risks must be managed through existing mechanisms within the UPC, rather than solely relying on accelerated timetables.

Jurisdiction
European UPC
Court
Luxembourg (LU)
Case Number
App_45041/2024
Judge(s)
Peter Blok; and judge

What the Court Held — Ratio Decidendi

The court ruled that the potential risk of an injunction based on a patent under appeal is not sufficient grounds to expedite proceedings. It emphasized that the Local Division has mechanisms (like staying infringement proceedings) to mitigate this risk, and Meril's complaints regarding legal errors fall within the scope of merits examination.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Luxembourg (LU). Understanding the court's reasoning in Meril Italy Srl vs Edwards Lifesciences Corporation is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentApp_2740/2025

Avago Technologies International Sales Pte. LimitedvsRealtek Semiconductor Corporation

This UPC decision addresses a procedural gap regarding the reimbursement of court fees when an application for interim measures is withdrawn. The Court ruled that despite the strict wording of the Rules of Procedure, the principle allowing fee recovery upon withdrawal could be analogously applied to interim measure applications. This provides clarity and predictability for practitioners dealing with early-stage litigation in the UPC.

patentApp_34962/2025

Huawei Technologies Co. LtdvsMediaTek, Inc.

In a complex infringement case involving Huawei and MediaTek concerning 5G-capable Dimensity chips, the UPC issued an interim procedural order focusing on confidentiality. The court granted extensive protection for trade secrets related to licensing agreements, limiting access to highly sensitive information only to specific parties. This decision highlights the UPC's robust mechanisms for managing confidential data during litigation, which is crucial in high-tech patent disputes.

patentUPC_CoA_678/2025

Hurom Co., Ltd.vsNUC Electronics Co., Ltd, NUC Electronics Europe GmbH and WARMCOOK

This UPC Court of Appeal decision addresses a procedural application for further written pleadings during an ongoing infringement appeal. The claimant, Hurom, sought additional time to respond to new arguments and prior art documents introduced by the respondents (NUC). The court ultimately rejected this request, prioritizing the principle of efficient conduct and the upcoming oral hearing. This ruling reinforces the strict procedural timelines within the UPC's written phase.

patentUPC_CFI_858/2025

Boehringer Ingelheim International GMBHvsZentiva Portugal, Lda.

In this preliminary ruling, the UPC confirmed its exclusive jurisdiction over a pharmaceutical patent infringement case involving nintedanib. The Defendant attempted to challenge the Court's competence by arguing that the dispute was administrative, stemming from a national health authority's communication. However, the UPC rejected this objection, clarifying that the core issue is a private enforcement action based on the threat of infringement, not an administrative review. This decision allows the case to proceed to the substantive merits phase.

patentUPC_CFI_344/2025

Irdeto B.V.vsSZ DJI Technology Co., Ltd.

This procedural order from the Mannheim Local Division addresses a dispute over court fees related to counterclaims for revocation. The claimant, Irdeto B.V., initiated an infringement action against several defendants, including SZ DJI Technology Co., Ltd. The core issue was whether Defendant 1 could use the fee paid by Defendants 2-4 when submitting its own counterclaim later. The Court ruled that because Defendant 1's submission constituted a separate action/counterclaim in time, it must pay a distinct court fee.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call